Danish Stocks: Nasdaq Copenhagen and the C25 Index

Nasdaq Copenhagen is home to some of Europe's most globally respected companies — and is dramatically skewed by one of them. Novo Nordisk's rise to become one of the world's largest companies by market cap has made Denmark's exchange an outsized contributor to Nordic and European equity performance, while companies like Vestas, DSV, Genmab, and Ørsted ensure Copenhagen is more than a single-stock story. For European equity investors, Denmark offers world-class compounders in healthcare, logistics, and clean energy.

Last updated: July 2026.

What Nasdaq Copenhagen covers

OMX Copenhagen 25 (C25): The headline Danish equity index, covering the 25 most liquid and largest companies listed on Nasdaq Copenhagen. Cap-weighted and heavily influenced by Novo Nordisk.

OMX Copenhagen GI: The broader index covering all listed Danish companies. More representative of the full Danish market.

Nasdaq First North Denmark: The alternative market for smaller Danish companies — lighter listing requirements, smaller capitalisation profiles. Approximately 50–80 companies.

Market size: Denmark's total listed equity market cap is one of the largest in Europe relative to GDP, driven by the extraordinary market capitalisation of Novo Nordisk (which at peak accounted for more than 150% of Denmark's annual GDP). Removing Novo Nordisk, the remaining Danish listed market is comparable to other Nordic countries.

Novo Nordisk: the elephant in the room

Any analysis of Danish equities must begin with Novo Nordisk, because it distorts every aggregate metric for the Copenhagen exchange.

Novo Nordisk produces insulin, GLP-1 drugs (Ozempic, Wegovy, Rybelsus) for type 2 diabetes and obesity, and haemophilia treatments. The GLP-1 category has become one of the largest drug categories in pharmaceutical history, giving Novo Nordisk revenue growth rates of 30–60% per year in 2023–2025 and driving the share price to valuations (P/E above 30–40x) that would be extreme for most industrial companies.

For screeners: Novo Nordisk will almost never appear in value or low-P/E screens. It will dominate quality and growth screens. Its weight in any pan-Danish or Nordic screen is so large that filtering without explicitly excluding or capping it may produce misleading results about the rest of the market.

Key sectors and major companies

Healthcare and pharmaceuticals

Novo Nordisk (GLP-1 drugs, insulin) is the market cap anchor. Genmab is a specialist oncology biotech with a royalty-driven model producing high margins. Bavarian Nordic (vaccines) is smaller but a legitimate European biotech.

Shipping and logistics

DSV is one of the world's largest freight forwarders — a consistent acquirer and integrator with exceptional operational efficiency. A.P. Møller-Mærsk (known as Maersk) is the world's second-largest container shipping company. Both are global leaders; both are affected by shipping cycle volatility. Maersk has been restructuring toward logistics and away from pure shipping to reduce cyclicality.

Wind energy

Vestas is the world's largest wind turbine manufacturer by installed capacity. Ørsted (formerly DONG Energy) is the global leader in offshore wind, with a project portfolio spanning Europe and the US. Both are heavily exposed to clean energy policy, interest rates (infrastructure projects are long-duration), and supply chain costs. They screen very differently depending on whether you use trough-cycle or peak-cycle earnings.

Consumer goods

Carlsberg is one of Europe's largest brewers. Pandora is the world's largest jewellery brand by production volume. Both trade on more moderate multiples than healthcare peers and suit income-quality screening approaches.

Healthcare technology

Coloplast produces medical devices (ostomy care, urology). Demant is a hearing aid manufacturer competing with William Demant, GN Audio, and Sonova. Both companies have consistent growth records and high EBIT margins (20%+).

Screening Danish stocks: practical approach

Exchange selection

Danish companies listed on Nasdaq Copenhagen appear in screeners that cover Nasdaq Nordic exchanges. First North Denmark companies may require explicitly selecting the alternative market in your filter setup.

Novo Nordisk weight management

For systematic screening: if you want to understand the Danish market ex-Novo Nordisk, apply a P/E filter (< 30) or set a market cap cap (< €50B). Novo Nordisk will fall outside a value screen automatically, but will dominate any quality or growth screen at very high weight.

Nordic sector adjustments

Danish industrials, logistics, and consumer goods tend to trade at premium multiples versus Southern European peers — reflecting higher governance standards, lower political risk, and more predictable earnings growth. A P/E of 20 on a Danish consumer goods company is cheaper than a similar multiple on a French equivalent if Danish companies have historically traded higher and grown more reliably.

Practical Danish equity screen

First North Denmark: the alternative market

Nasdaq First North Denmark lists approximately 50–80 smaller Danish companies. Fundamental data availability varies significantly. Notable sectors: fintech, medtech, and speciality food. The quality range is wide — from legitimate high-growth companies to pre-revenue speculative names. Apply a minimum market cap filter (€30M+) and verify that the screener provides actual fundamental data for First North names before screening.

Dividend withholding tax

Denmark withholds 15% on dividends to investors resident in EU/EEA countries and countries with applicable tax treaties. The rate for non-treaty residents is 27%. Most European investors and US investors automatically receive the 15% treaty rate, which can often be further reduced to 0% in specific treaty situations. For income-focused investors, 15% is the practical effective rate for most foreign holders.

How Denmark fits in a European portfolio

Danish stocks offer:

• World-class compounders — Novo Nordisk, DSV, Coloplast, and Genmab represent some of the highest-quality businesses listed on any European exchange
• Clean energy exposure — Vestas and Ørsted provide wind energy leadership for ESG-focused investors
• Healthcare diversification — Denmark has the densest concentration of quality healthcare companies per capita in Europe
• Premium valuation — Danish quality comes at a price; value screens in Denmark are less productive than in Southern or Eastern Europe

A reasonable allocation in a pan-European quality-growth portfolio: 8–12% Danish exposure, concentrated in DSV and Coloplast for quality compounders, with Vestas as a clean energy allocation.

Bottom line

Nasdaq Copenhagen is a high-quality exchange anchored by world-class businesses in healthcare, logistics, and wind energy. The Novo Nordisk dominance means aggregate index metrics are almost meaningless — the exchange's quality lies in the second tier: DSV's logistics excellence, Genmab's oncology royalties, Coloplast's medical device consistency, and Pandora's brand manufacturing. Screen Denmark with quality and growth filters, manage the Novo Nordisk weight explicitly, and treat First North as a separate, more speculative universe.

Frequently asked questions

What is the C25 index?

The OMX Copenhagen 25 (C25) is the benchmark index for Nasdaq Copenhagen, covering the 25 most liquid Danish listed companies. It is cap-weighted and heavily dominated by Novo Nordisk, which at times has represented 50–70% of the entire index weight. This concentration means C25 performance primarily reflects Novo Nordisk's share price movement rather than the broader Danish market.

Is Denmark a good market for dividend investors?

Denmark has several reliable dividend payers — Carlsberg, Pandora, and A.P. Møller-Mærsk have historically paid meaningful dividends. Overall dividend yields on Danish stocks are moderate compared to UK or Southern European markets, as high-quality Danish companies tend to reinvest for growth. The 15% withholding rate is reasonable for most foreign investors. For high-yield income, other European markets (UK, Southern Europe, Nordic utilities) are more productive hunting grounds.

What sectors dominate Nasdaq Copenhagen?

Healthcare (led by Novo Nordisk, Genmab, Coloplast) and industrials/logistics (DSV, Maersk) are the dominant sectors. Clean energy (Vestas, Ørsted) is a distinctive Danish position. Consumer (Carlsberg, Pandora) and financials (Danske Bank) round out the main sectors. Technology is underrepresented relative to Nordic peers like Sweden's Nasdaq Stockholm.

How do I screen Danish small caps?

Danish small caps trade on Nasdaq First North Denmark. Filter by exchange (First North Denmark) in screeners with Nordic coverage. Apply a market cap floor of €30–50M to filter out pre-revenue names, and verify that the screener provides actual fundamental data rather than just a listing. First North Denmark is more productive for growth stock discovery than value screening — small Danish companies tend to be growth-oriented businesses rather than cheap value situations.

Screen Danish and Nordic stocks → — free, no account required. Covers Nasdaq Copenhagen, First North Denmark, Nasdaq Stockholm, Oslo Børs, and all major European exchanges.